Overview

Substance Abuse Pre-Treatment Screening Study

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The overarching goal of this project is to have a consolidated consent and evaluation procedure that will lead potential subjects to the most appropriate clinical trial or human laboratory study (and its consent process) for their presenting concerns or interests. A second purpose is to have a consolidated intake data base on which secondary analyses can be conducted.
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Amphetamine
Dextroamphetamine
Modafinil
Naltrexone